Xencor Inc (NAS:XNCR)
$ 23.96 0.2 (0.84%) Market Cap: 1.48 Bil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 2.41 GF Score: 71/100

Xencor Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:45PM GMT
Release Date Price: $27.25 (+1.04%)
Lut Ming Cheng
JPMorgan Chase & Co, Research Division - Research Analyst

Good afternoon. Thanks for joining us for another session at the 41st JPMorgan Healthcare Conference. I'm Brian Cheng. I'm one of the senior covering analysts at JPMorgan. Presenting next is Xencor. I'll turn over the stage to the management team. After the presentation, we will follow up with a Q&A session.

Bassil I. Dahiyat
Xencor, Inc. - Co-Founder, CEO, President & Director

Thanks so much, Brian. It's a pleasure to be back at JPMorgan in person. My name is Bassil Dahiyat, I'm the CEO at Xencor. And I'll kick it off by showing you our forward-looking statements slide. So we are a protein engineering company. That's we were spun out of Caltech 25 years ago to do. That's still the core of everything we do. We focus our engineering work on manipulating immunology molecules in the body, mostly antibodies and cytokines. And we've built a very modular toolkit of different domains of these structures that we use to construct drugs, both for ourselves and our partners.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot